4th Quarter - Termination
OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC. for OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC.
Income
—
Expenses
$180,000
Expense method
A: Lobbying Disclosure Act definitions
Terminated
Dec 31, 2015
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
S. 481: Improving Regulatory Transparency for New Medical Therapies Act, S. 1945: Mental Health Reform Act of 2015, S. 1893: Mental Health Awareness and Improvement Act of 2015, H.R. 2646: Helping Families in Mental Health Crisis Act of 2015
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN BARDI | — |
| MOLLY RYAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.